HomeCompareGNGBF vs NNN

GNGBF vs NNN: Dividend Comparison 2026

GNGBF yields 2.06% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNGBF wins by $72.79M in total portfolio value
10 years
GNGBF
GNGBF
● Live price
2.06%
Share price
$23.23
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.81M
Annual income
$66,602,057.77
Full GNGBF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — GNGBF vs NNN

📍 GNGBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNGBFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNGBF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNGBF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNGBF
Annual income on $10K today (after 15% tax)
$175.05/yr
After 10yr DRIP, annual income (after tax)
$56,611,749.10/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, GNGBF beats the other by $56,609,519.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNGBF + NNN for your $10,000?

GNGBF: 50%NNN: 50%
100% NNN50/50100% GNGBF
Portfolio after 10yr
$36.42M
Annual income
$33,302,340.22/yr
Blended yield
91.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

GNGBF
No analyst data
Altman Z
2.7
Piotroski
7/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNGBF buys
0
NNN buys
0
No recent congressional trades found for GNGBF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNGBFNNN
Forward yield2.06%5.66%
Annual dividend / share$0.48$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%8.6%
Portfolio after 10y$72.81M$25.5K
Annual income after 10y$66,602,057.77$2,622.67
Total dividends collected$72.32M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: GNGBF vs NNN ($10,000, DRIP)

YearGNGBF PortfolioGNGBF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,112$411.88$10,735$614.96+$377.00GNGBF
2$12,745$855.47$11,572$708.43+$1.2KGNGBF
3$15,471$1,834.05$12,531$819.53+$2.9KGNGBF
4$20,716$4,161.41$13,633$952.29+$7.1KGNGBF
5$32,581$10,414.98$14,909$1,111.84+$17.7KGNGBF
6$65,479$30,617.23$16,392$1,304.77+$49.1KGNGBF
7$185,076$115,013.77$18,129$1,539.52+$166.9KGNGBF
8$805,671$607,639.15$20,173$1,827.08+$785.5KGNGBF
9$5,806,303$4,944,235.96$22,597$2,181.81+$5.78MGNGBF
10$72,814,802$66,602,057.77$25,491$2,622.67+$72.79MGNGBF

GNGBF vs NNN: Complete Analysis 2026

GNGBFStock

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Full GNGBF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this GNGBF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNGBF vs SCHDGNGBF vs JEPIGNGBF vs OGNGBF vs KOGNGBF vs MAINGNGBF vs ADCGNGBF vs EPRTGNGBF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.